- Finnish expertise in the medicine sector is very strong, particularly in fields that are important with regard to the future. We have specific expertise and biobanks and soon we will establish a genome centre. Biomedicine expertise is strong in Finland. The European Medicines Agency, EMA, is a large agency that would further strengthen the Finnish health sector expertise and also improve employment in our country.
The Finnish pharmaceutical service is functioning well and medicine safety is on a top level in Finland. The Finnish Medicines Agency FIMEA is a highly respected authority in Europe and plays a significant role in EMA's operation.
According to the Minister, relocating EMA to Finland would also give synergy benefits with the European Chemicals Agency. When both EU agencies would be located in Finland, their cooperation could be further intensified.
- The synergy benefit is an important justification for relocating EMA to Finland. Minister Mattila reminds that other countries do not have this benefit.
- Finland is a safe country with stable society. We can offer modern facilities for EMA. Our good ICT expertise will ensure the maintenance and development of the agency's ICT technology, Minister Mattila adds.
Read the entire article here.